NCT06682117 2024-11-19
Neo-DCV-001
Fudan University
Phase NA Recruiting
Clinical Trials
24 trialsNCT01803152 2024-07-03
Dendritic Cell Vaccine for Children and Adults With Sarcoma
University of Miami
Phase 1 Completed
NCT03730948 2024-05-24
DC Vaccine in Colorectal Cancer
University of Pennsylvania
Phase 1 Terminated
NCT01686334 2024-03-12
WIDEA
University Hospital, Antwerp
Phase 2 Active not recruiting
NCT05321940 2023-12-04
Safety Trial of STING-dependent Activators and Stimulated Dendritic Cells for Aggressive Relapsed/Refractory Leukemias
University of Miami
Phase 1 Withdrawn
NCT06043232 2023-09-21
MMR/MSI Phenotypes in Prediction of Tumor Vaccine Benefit for Gliomas
Huashan Hospital
Recruiting
NCT02543749 2023-02-09
DC Vaccination in CML
Charite University, Berlin, Germany
Phase 1/2 Terminated
NCT02334735 2022-09-15
A Comparison of Matured Dendritic Cells and Montanide® in Study Subjects With High Risk of Melanoma Recurrence
Icahn School of Medicine at Mount Sinai
Phase 2 Completed
NCT01808820 2022-07-20
Dendritic Cell (DC) Vaccine for Malignant Glioma and Glioblastoma
University of Miami
Phase 1 Completed
NCT05000801 2021-08-20
Clinical Study of DC-AML Cells in the Treatment of Acute Myeloid Leukemia
Affiliated Hospital to Academy of Military Medical Sciences
Phase NA Recruiting
NCT04567069 2020-09-28
Safety and Efficacy Study for MG-7-DC Vaccine in Gastric Cancer Treatment
The Second Hospital of Shandong University
Phase 1/2 Unknown
NCT02151448 2020-07-20
αDC1 Vaccine + Chemokine Modulatory Regimen (CKM) as Adjuvant Treatment of Peritoneal Surface Malignancies
University of Pittsburgh
Phase 1/2 Completed
NCT02529072 2020-03-26
AVERT
Duke University
Phase 1 Completed
NCT01883518 2019-11-20
ADCVCTAST
N.N. Petrov National Medical Research Center of Oncology
Phase 1/2 Unknown
NCT01876212 2019-08-22
Dendritic Cell Vaccines + Dasatinib for Metastatic Melanoma
University of Pittsburgh
Phase 2 Completed
NCT00085436 2018-06-26
DC Vaccine Combined With IL-2 and IFNα-2a in Treating Patients With mRCC
Dartmouth-Hitchcock Medical Center
Phase 2 Completed
NCT02956551 2018-05-31
SKLB1608
Sichuan University
Phase 1 Unknown
NCT01671592 2017-09-26
Safety of Labeled Dendritic Cell (DC) Vaccines and Feasibility of Tracking by Magnetic Resonance Imaging (MRI)
University of Pittsburgh
Phase 1 Completed
NCT00103116 2017-04-04
Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer
University of Kentucky
Phase 2 Completed
NCT01902771 2017-03-10
Dendritic Cell Vaccine Therapy With In Situ Maturation in Pediatric Brain Tumors
University of Miami
Phase 1 Terminated
NCT00913913 2015-12-01
Bevacizumab, Autologous Tumor/DC Vaccine, IL-2 and IFNα-2b in Metastatic Renal Cell Carcinoma (RCC) Patients
Dartmouth-Hitchcock Medical Center
Phase 2 Terminated
NCT00978913 2015-08-19
Transfected Dendritic Cell Based Therapy for Patients With Breast Cancer or Malignant Melanoma
Herlev Hospital
Phase 1 Completed
NCT00935558 2012-05-31
Dendritic Cell Based Therapy for Breast Cancer Patients
Herlev Hospital
Phase 2 Withdrawn
NCT00327496 2006-05-18
Cytotoxicity Induced by Tumor Lysate Pulsed Dendritic Cells Against Autologous Hepatocellular Carcinoma Cells
Mackay Memorial Hospital
Phase NA Unknown